Literature DB >> 7030765

The role of histocompatibility antigens (HLA) in infection.

R A Kaslow, S Shaw.   

Abstract

We have tried to describe and evaluate in epidemiologic terms what has been done in less than a decade to define the influence of a unique genetic system on susceptibility and response to infection. The extent of its influence on disease susceptibility has only begun to be measured, and our understanding of the mechanistic and functional aspects of HLA and disease association is in its infancy. We hope it is clear from the foregoing review that the immunogeneticist, the epidemiologist, and the biostatistician all have much to offer each other as the work progresses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030765     DOI: 10.1093/oxfordjournals.epirev.a036241

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN: 0193-936X            Impact factor:   6.222


  4 in total

Review 1.  Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.

Authors:  Vincent van Drongelen; Joseph Holoshitz
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

2.  HLA studies in brucellar spondylitis.

Authors:  G S Alarcón; E Gotuzzo; S A Hinostroza; C Carrillo; T S Bocanegra; L R Espinoza
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

3.  HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation.

Authors:  H W Roenhorst; A M Tegzess; J M Beelen; J M Middeldorp; T H The
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-07

4.  Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.

Authors:  F W Miller; W Chen; T P O'Hanlon; R G Cooper; J Vencovsky; L G Rider; K Danko; L R Wedderburn; I E Lundberg; L M Pachman; A M Reed; S R Ytterberg; L Padyukov; A Selva-O'Callaghan; T R Radstake; D A Isenberg; H Chinoy; W E R Ollier; P Scheet; B Peng; A Lee; J Byun; J A Lamb; P K Gregersen; C I Amos
Journal:  Genes Immun       Date:  2015-08-20       Impact factor: 2.676

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.